F&E, Pharmakovigilanz & Regulatory Affairs

F&E, Pharmakovigilanz & Regulatory Affairs

Forschung, Entwicklung, Testung und Einführung neuer Arzneimittel. Der Entwicklungsprozess dauert 8 bis 10 Jahre und besteht aus 4 Phasen.

  • F&E, Pharmakovigilanz & Regulatory Affairs

    Forschung, Entwicklung, Testung und Einführung neuer Arzneimittel. Der Entwicklungsprozess dauert 8 bis 10 Jahre und besteht aus 4 Phasen.
Stellenbezeichnung Standort Sort descending Datum Req ID
Zurücksetzen
PV/RA Manager
PV/RA Manager Zaventem, BE 11.09.2026 7643
Zaventem, BE 11.09.2026 7643
Head of Clinical Data Innovation
Head of Clinical Data Innovation Remote, IT 02.09.2026 7660
Remote, IT 02.09.2026 7660
INTERN - Patient Engagement
INTERN - Patient Engagement PARMA, IT 20.08.2026 5993
PARMA, IT 20.08.2026 5993
GRAPS Safety Operations, Clinical Trials Manager
GRAPS Safety Operations, Clinical Trials Manager Parma, IT 28.08.2026 7442
Parma, IT 28.08.2026 7442
Statistical Programmer
Statistical Programmer Parma, IT 04.09.2026 7444
Parma, IT 04.09.2026 7444
PSMF & Compliance Manager
PSMF & Compliance Manager Parma, IT 03.09.2026 7452
Parma, IT 03.09.2026 7452
R&D Bioinformatician Lead
R&D Bioinformatician Lead Parma, IT 06.09.2026 7280
Parma, IT 06.09.2026 7280
R&D Process Excellence & Digital Solutions Senior Manager
R&D Process Excellence & Digital Solutions Senior Manager Parma, IT 15.09.2026 7313
Parma, IT 15.09.2026 7313
GRAPS Patient Safety Operations, Post Marketing Manager
GRAPS Patient Safety Operations, Post Marketing Manager Parma, IT 28.08.2026 7580
Parma, IT 28.08.2026 7580
Principal Statistician, Global Rare Diseases
Principal Statistician, Global Rare Diseases Parma, IT 27.08.2026 7555
Parma, IT 27.08.2026 7555
Patient Safety Science Lead
Patient Safety Science Lead Parma, IT 22.08.2026 7546
Parma, IT 22.08.2026 7546
Senior Process Scientist - gRNA process development
Senior Process Scientist - gRNA process development Parma, IT 30.08.2026 7404
Parma, IT 30.08.2026 7404
Senior Director, Clinical Biometrics & Analytics
Senior Director, Clinical Biometrics & Analytics Parma, IT 03.09.2026 6387
Parma, IT 03.09.2026 6387
Senior Technical Leader, Protein Biologics Development, GRD CMC
Senior Technical Leader, Protein Biologics Development, GRD CMC Parma, IT 10.09.2026 7605
Parma, IT 10.09.2026 7605
Principal Regulatory Writer, Global Rare Diseases
Principal Regulatory Writer, Global Rare Diseases Parma, IT 06.09.2026 7341
Parma, IT 06.09.2026 7341
Senior Technical Leader, GRD CMC
Senior Technical Leader, GRD CMC Parma, IT 10.09.2026 7607
Parma, IT 10.09.2026 7607
Senior Analytical Scientist - LNP/RNA analytics
Senior Analytical Scientist - LNP/RNA analytics Parma, IT 30.08.2026 7403
Parma, IT 30.08.2026 7403
Senior Manager, CMC Regulatory Affairs, Global Rare Diseases
Senior Manager, CMC Regulatory Affairs, Global Rare Diseases Parma, IT 13.09.2026 7394
Parma, IT 13.09.2026 7394
R&D GRAPS Affiliate and Partnership Oversight Unit Head
R&D GRAPS Affiliate and Partnership Oversight Unit Head Parma, IT 31.08.2026 7103
Parma, IT 31.08.2026 7103
Senior Technical Leader, Analytical Method Development and Validation, GRD CMC
Senior Technical Leader, Analytical Method Development and Validation, GRD CMC Parma, IT 10.09.2026 7606
Parma, IT 10.09.2026 7606
R&D Data Visualization Engineer
R&D Data Visualization Engineer Parma, IT 13.09.2026 7301
Parma, IT 13.09.2026 7301
Clinical Partnership Manager
Clinical Partnership Manager Parma or Chiesi Affiliates in , IT 03.09.2026 7659
Parma or Chiesi Affiliates in , IT 03.09.2026 7659
Specialist Care Therapeutic Area, Global Regulatory Affairs and Patient Safety - Temporary
Specialist Care Therapeutic Area, Global Regulatory Affairs and Patient Safety - Temporary Paris, Bois Colombes, FR 03.09.2026 7450
Paris, Bois Colombes, FR 03.09.2026 7450
Head of Clinical Project Management
Head of Clinical Project Management Italy, IT 21.08.2026 7386
Italy, IT 21.08.2026 7386
Pharmazeut (all genders) im Praktikum für 2027
Pharmazeut (all genders) im Praktikum für 2027 Hamburg, DE 28.08.2026 351
Hamburg, DE 28.08.2026 351